| Literature DB >> 30475660 |
Sue Barber-Westin1, Frank R Noyes1.
Abstract
CONTEXT:: Blood flow-restricted training (BFRT) has been suggested to treat lower extremity muscle weakness. The efficacy of BFRT for muscle problems related to knee pathology is unclear.Entities:
Keywords: blood flow resistance training; quadriceps strengthening; resistance training
Mesh:
Year: 2018 PMID: 30475660 PMCID: PMC6299354 DOI: 10.1177/1941738118811337
Source DB: PubMed Journal: Sports Health ISSN: 1941-0921 Impact factor: 3.843
Figure 1.Examples of blood flow restriction exercise training that may be done nonweightbearing, such as (a) during knee extension, or weightbearing, such as (b) during partial squatting.
Reasons for 525 articles excluded
| Exclusion Criteria | Articles, n |
|---|---|
| Off-topic | 205 |
| Acute effects training | 92 |
| Training in healthy participants or athletes | 55 |
| Physiology-based study | 38 |
| General review | 28 |
| Upper body training | 22 |
| Training in elderly patients | 22 |
| Case report or series | 12 |
| Study effect of cuff pressure | 11 |
| Editorial | 11 |
| Systematic review/meta-analysis | 8 |
| Laboratory (animal) study | 7 |
| Effects training after immobilization | 5 |
| Study protocol only (no results) | 4 |
| Study diseases (cardiovascular, obesity, polymyositis) | 4 |
| Survey | 1 |
Study protocols
| Study Group | Protocol | |||||
|---|---|---|---|---|---|---|
| Study (Level of Evidence), Diagnosis | BFRT | Control | Treatment Sessions (Total Possible) | Cuff Material, Size, Pressure | Occlusion | Exercise During Occlusion |
| Ohta et al[ | 19 males | 12 males | 2×/day | Air tourniquet, 180 mm Hg | Inflate duration of training, maximum 15 min. Remove 15-20 min, resume if required | Straight-leg raises, hip abduction and adduction isometrics, quadriceps isometrics, half-squats, step-ups, walk in deep flexion, elastic tube squat resistance. 20 reps 2×/day |
| Takarada et al[ | 4 males | 4 males | 2×/daydays 1-15 p.o. | Pneumatic cuff width 9 cm, length 70 cm. 180 mm Hg, gradually elevated 10 mm Hg depending on patient tolerance (range, 200-260 mm Hg). Placebo cuff control group | Inflate 5 min, deflate 3 min, repeat 5× | None |
| Iversen et al[ | 7 males | 7 males | 2×/day | Delphi low-pressure cuff, 14-cm wide. 130 mm Hg, increased 10 mm Hg, maximum 180 mm Hg | Inflate 5 min during exercise, deflate 3 min, repeat 5× | Quadriceps isometrics, leg extensions over knee roll, straight-leg raises. 20 reps each × 5 per session |
| Tennent et al[ | 7 males | 5 males | 12 sessions | Easy-Fit Tourniquet cuff, size varied based on thigh size. Set to 70% of total arterial occlusal pressure | Inflate during exercise, maximum 5 min | 30% 1 RM BFRT: leg press, knee extension, reverse press, 1 set 30 reps, 3 sets 15 reps |
| Segal et al[ | 19 males | 22 males | 3×/wk × 4 wk | Kaatsu Master BFR device, width 6.5 cm, length 65 cm. 160-200 mm Hg, gradually increased during training sessions | Inflate 5 min during exercise, deflate 1.5 min rest between sets | 30% 1 RM both groups: leg press, 1 set 30 reps, 3 sets 15 reps |
| Segal et al[ | 19 females | 21 females | 3×/wk × 4 wk | Kaatsu Master BFR device, width 6.5 cm, length 65 cm. 160-200 mm Hg, gradually increased during training sessions | Inflate 5 min during exercise, deflate 1.5 min, rest between sets | 30% 1 RM both groups: leg press, knee extension, reverse press, 1 set 30 reps, 3 sets 15 reps |
| Bryk et al[ | 17 females | 17 females | 3×/wk × 6 wk(18), in clinic | Cuff details NA. 200 mm Hg | Inflate during quadriceps exercises (time NA) | 30% 1 RM BFRT, 70% 1 RM controls: knee extension machine. BFRT 3 sets 30 reps, controls 3 sets 10 reps |
| Ferraz et al[ | 12 females | HR group: | 2×/wk × 12 wk (24), in clinic | Cuff details NA. | Inflate during exercises and rest periods | 30% 1 RM BFRT and LR controls, 80% 1 RM HR controls. 4-5 sets × 10 reps |
| Giles et al[ | 16 males | 20 males | 3×/wk × 8 wk | Cuff details NA. | Inflate during exercise (time NA), deflate 30 s, rest between sets | 30% 1 RM BFRT, 70% 1 RM controls: leg press, knee extension. BFRT 1 set 30 reps, 3 sets 15 reps. Controls 3 sets 7-10 reps |
ACL, anterior cruciate ligament; BFRT, blood flow–restricted training; HR, high resistance; LR, low resistance; NA, not available; p.o., postoperative; reps, repetitions; RM, repetition maximum.
Changes in quadriceps strength and muscle cross-sectional area after training[ ]
| Quadriceps Strength | Muscle CSA, Biopsy | |||||
|---|---|---|---|---|---|---|
| Study | Data | Within-Group | Between-Groups | Data | Within-Group | Between-Groups |
| Ohta et al[ | Involved-uninvolved ratios | MRI CSA I/N ratios (preop: 16 wk postop) | ||||
| 60 deg/s: BFRT, 76% ± 16%; control, 55% ± 17% | NA | Quadriceps: BFRT, 101% ± 11%; control, 92% ± 12% | NA | |||
| 180 deg/s: BFRT, 77% ± 13%; control, 65% ± 13% | NA | Hamstrings: BFRT, 105% ± 19%; control, 102% ± 23% | NA | |||
| Isometric: BFRT, 84% ± 19%; control, 63% ± 19% | NA | Diameters type 1, 2 fibers medial vastus lateralis | NA | |||
| Takarada et al[ | Not measured | MRI CSA % decrease from 3rd to 14th postop day | ||||
| Quadriceps: BFRT, 9.4% ± 1.6%; control, 20.7% ± 2.2% | ||||||
| Hamstrings: BFRT, 9.2% ± 2.6%; control, 11.3% ± 2.6% | ||||||
| Iversen et al[ | Not measured | MRI CSA % decrease from 2nd to 16th postop day | ||||
| Quadriceps: BFRT, 13.8% ± 1.1%; control, 13.1% ± 1.0% | NA | |||||
| Tennent et al[ | 60 deg/s N·m/kg (% improvement[ | Not done | ||||
| BFRT pre: 99.83; post: 211.92 (75%) | ||||||
| Control pre: 126.7; post: 171.5 (33.5%) | ||||||
| Segal et al[ 4 wk posttraining | 60 deg/s N·m mean increase (% improvement) | Not done | ||||
| BFRT: –0.1 ± 3.3 N·m (0.4%) | ||||||
| Control: 7.0 ± 3.0 N·m (6.7%) | ||||||
| Leg press 1 RM kg mean increase (% improvement) | ||||||
| BFRT: 11.3 ± 14.0 (3.1%) | ||||||
| Control: 13.5 ± 16.8 (4.7%) | ||||||
| Segal et al[ 4 wk posttraining | 60 deg/s N·m/kg mean increase | MRI volume % increase | ||||
| BFRT: 0.07 ± 0.03 | Quadriceps: BFRT, 1.3% ±0.80%; control, 0.01% ± 0.73% | |||||
| Control: −0.05 ± 0.03 | ||||||
| Leg press 1 RM kg mean increase | ||||||
| BFRT: 28.3 ± 4.8 | ||||||
| Control: 15.6 ± 4.5 | ||||||
| Bryk et al[ | Isometric kg force/kg body weight (% improvement) | Not done | ||||
| BFRT pre: 23.2 ± 8.4; post: 40.0 ± 0.2 (17%) | ||||||
| Control pre: 24.1 ± 10.1; post: 33.5 ± 12.9 (9%) | ||||||
| Ferraz et al[ | Leg press 1 RM % improvement | CT CSA % increase quadriceps | ||||
| BFRT: 26% | ||||||
| High-resistance group: 33% | BFRT: 7% | |||||
| Low-resistance group: 8% | ||||||
| Knee extension 1 RM % improvement | High-resistance group: 8% | |||||
| BFRT: 23% | ||||||
| High-resistance group: 22% | Low-resistance group: 2% | |||||
| LR control: 7% | ||||||
| Giles et al[ | Isometric N·m (% improvement) | Ultrasound quadriceps size (cm) | ||||
| BFRT pre: 131.2 ± 61.9; post: 166.4 ± 59.4 (27%) | BFTR pre: 7.9 ± 1.3; post: 8.0 ± 1.1 | NS | ||||
| Control pre: 135.1 ± 55; post: 158.7 ± 57.4 (17%) | Control pre: 7.7 ± 1.4; post: 7.9 ± 1.2 | NS | ||||
ACL, anterior cruciate ligament; BFRT, blood flow–restricted training; CSA, cross-sectional area; CT, computed tomography; ES, effect size; HR, high resistance; I/N, involved/noninvolved; LR, low resistance; MRI, magnetic resonance imaging; NA, not available; NS, not significant; RM, repetition maximum.
Data are shown as means ± SDs (when available). Percentage improvement data provided when available. ESs calculated according to Cohen when possible.
When outliers (1 from each group) removed.
Effect of training on outcome scales
| BFRT Group | Control Group | |||||||
|---|---|---|---|---|---|---|---|---|
| Study | Outcome Scale | Pre-training | Post-training |
| Pre-training | Post-training |
| Between-Group Comparison, |
| Tennent et al[ | KOOS | |||||||
| Pain | 52.8 | 75.0 | 0.0001 | 69.4 | 77.8 | 0.04 | NS | |
| Symptoms | 47.1 | 76.8 | 0.003 | 67.9 | 71.4 | NS | NS | |
| ADL | 58.1 | 88.2 | 0.0009 | 73.5 | 75.0 | NS | NS | |
| QOL | 31.3 | 59.3 | 0.003 | 43.8 | 62.5 | NS | NS | |
| Sport | 10.0 | 47.5 | 0.0009 | 35.0 | 70.0 | 0.04 | NS | |
| VR-12 | ||||||||
| PCS | 0.86 | 46.3 | 0.001 | 36.5 | 47.7 | 0.04 | NS | |
| MCS | 51.20 | 60.2 | 0.04 | 57.6 | 56.2 | NS | 0.01 | |
| Segal et al[ | KOOS | |||||||
| Pain | ~83 | ~86 | NS | ~76 | ~81 | NS | NS | |
| Segal et al[ | KOOS | |||||||
| Pain | ~80 | ~82 | NS | ~76 | ~78 | NS | NS | |
| Bryk et al[ | Lequesne scale | 11.5 | 6.5 | 0.001 | 13.0 | 7.0 | 0.001 | NS |
| VAS knee pain | 6.5 | 3.2 | 0.001 | 6.0 | 3.5 | 0.001 | NS | |
| VAS knee pain with training | — | 2.5 | — | — | 6.2 | — | 0.01 | |
| Ferraz et al[ | WOMAC | HR | HR | |||||
| Pain | 6.9 | 4.0 | 0.02 | 7.2 | 4.0 | NS | NP | |
| Stiffness | 3.6 | 2.1 | 0.01 | 3.5 | 2.0 | NS | NP | |
| Physical function | 21.0 | 10.3 | 0.02 | 25.9 | 14.6 | 0.02 | NP | |
| Total score | 31.5 | 17.1 | 0.008 | 36.6 | 21.2 | 0.02 | NP | |
| WOMAC | LR | LR | ||||||
| Pain | 7.9 | 4.0 | 0.001 | NP | ||||
| Stiffness | 2.8 | 1.8 | NS | NP | ||||
| Physical function | 24.4 | 12.7 | NS | NP | ||||
| Total score | 35.1 | 18.4 | 0.005 | NP | ||||
| Giles et al[ | Kujala patellofemoral score | 73.6 | 86.5 | <0.001 | 72.6 | 83.2 | <0.001 | NS, ES = 0.23 |
| VAS worst pain | 55.7 | 27.4 | <0.001 | 51.4 | 25.6 | <0.001 | NS, ES = 0.27 | |
| VAS ADL | 58.2 | 21.6 | <0.001 | 42.5 | 24.1 | < 0.001 | 0.02, ES = 0.53 | |
ADL, activities of daily living; BFRT, blood flow–restricted training; ES, effect size; HR, high resistance; KOOS, Knee injury and Osteoarthritis Outcome Scores; LR, low resistance; MCS, mental component score; NP, not provided; NS, not significant; PCS, physical component score; QOL, quality of life; VAS, visual analog scale; VR-12, Veterans RAND 12-Item Health Survey; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Overall results[ ]
| Quadriceps Strength | Quadriceps CSA | Outcome Scales: Pain | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Study | Total No. Training Sessions Possible | Major Muscle Groups Exercised | Improved in BFRT Group? | BFRT Significantly Greater Than Control? | Improved in BFRT Group? | BFRT Significantly Greater Than Control? | Improved in BFRT Group? | BFRT significantly Greater Than Control? | BFRT Recommended? |
| Ohta et al[ | 210 | Quadriceps, hamstrings, hip | — | Yes | — | Yes | — | — | Yes |
| Takarada et al[ | 30 | None | — | — | Yes | Yes | — | — | Yes |
| Iversen et al[ | 30 | Quadriceps | — | — | — | No | — | — | No |
| Tennent et al[ | 12 | Quadriceps, hamstrings | Yes | Yes | — | — | Yes | No | Yes |
| Segal et al[ | 12 | Quadriceps | No | No | — | — | No | No | No |
| Segal et al[ | 12 | Quadriceps, hamstrings | Yes | Yes | No | No | No | No | Yes |
| Bryk et al[ | 18 | Quadriceps, hamstrings, hip, gastrocnemius | Yes | No | — | — | Yes | Yes | Yes |
| Ferraz et al[ | 24 | Quadriceps | Yes | Yes vs LR | Yes | Yes vs LR | Yes | No | Yes |
| Giles et al[ | 24 | Quadriceps | Yes | No | No | No | Yes | No | Yes |
ACL, anterior cruciate ligament; BFRT, blood flow–restricted training; CSA, cross-sectional area; HR, high resistance; LR, low resistance.
— = factor not analyzed in study.